Anti-angiogenic action of the C-terminal domain of tenomodulin that shares homology with chondromodulin-I
Open Access
- 1 June 2004
- journal article
- research article
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 117 (13) , 2731-2744
Abstract
Tenomodulin (TeM) is a type II transmembrane glycoprotein that contains a C-terminal domain with homology to the mature, secreted form of chondromodulin-I (ChM-I), a cartilage-derived angiogenesis inhibitor. TeM transcripts have been found in hypovascular tissues such as tendons and ligaments but the biological activity of TeM has not yet been fully explored. Using an adenovirus expression system, we utilized the forced expression and subsequent secretion of the human TeM C-terminal 116 amino acids (Ad-shTeM) in human umbilical vein endothelial cells (HUVECs) to assess the anti-angiogenic properties of TeM. The C-terminal 120 amino acids of the human ChM-I precursor (Ad-shChM-I) was similarly expressed in HUVECs as a comparison study. Transduction of both Ad-shTeM and Ad-shChM-I resulted in significant impairment of the tube-forming activity of HUVECs, when cultured in Matrigel. Similarly, conditioned medium from COS7 cells, transfected with plasmid DNA encoding shTeM or shChM-I, inhibited tube formation of HUVECs when compared to medium derived from either COS7 cells transfected with control vector or from non-transfected cells. Upon infection of HUVECs with Ad-shTeM or Ad-shChM-I, DNA synthesis stimulated by vascular endothelial growth factor (VEGF) was reduced to 40-50% of normal levels. Additionally, in a modified Boyden chamber assay, migration of HUVECs in response to VEGF was significantly affected following transduction of either Ad-shTeM or Ad-shChM-I and these transduced HUVECs were found to spread well on type I collagen or fibronectin, but not on vitronectin. Furthermore, the transduction of either Ad-shTeM or Ad-shChM-I in human melanoma cells resulted in suppression of tumor growth in association with decreased vessel density in vivo. Hence, we have demonstrated that, similarly to ChM-1, the C-terminal domain of TeM exhibits both anti-angiogenic and anti-tumor activities when expressed in a secreted form.Keywords
This publication has 41 references indexed in Scilit:
- Post-translational Processing of Bovine Chondromodulin-IJournal of Biological Chemistry, 2001
- A novel gene, tendin, is strongly expressed in tendons and ligaments and shows high homology with chondromodulin‐IDevelopmental Dynamics, 2001
- The cell and developmental biology of tendons and ligaments2000
- The role of αv integrins during angiogenesis: insights into potential mechanisms of action and clinical developmentJournal of Clinical Investigation, 1999
- ADAMs: focus on the protease domainCurrent Opinion in Cell Biology, 1998
- Kringle 5 of Plasminogen is a Novel Inhibitor of Endothelial Cell GrowthJournal of Biological Chemistry, 1997
- Abnormal blood vessel development and lethality in embryos lacking a single VEGF alleleNature, 1996
- Requirement of Vascular Integrin α v β 3 for AngiogenesisScience, 1994
- Mammalian subtilisins: The long-sought dibasic processing endoproteasesCell, 1991
- Angiogenesis in vitroNature, 1980